Muscle as the organ of longevity — and senescence as its threat
Healthspan's research section features an article calling skeletal muscle 'the organ of longevity' and cellular senescence its main threat — a specific claim from a commercial platform.
Healthspan sells rapamycin, methylene blue, and oxytocin. The platform published a "Top 10 Longevity Breakthroughs of 2025" roundup. On the same site — an article: "Skeletal Muscle Is the Organ of Longevity. Cellular Senescence Is What Threatens It Most."
The source is commercial, and we haven't seen the full text — can't assess the argument. The title, though, names a specific mechanism: cellular senescence.
In the Eternal Search longevity company ratings, Deciduous Therapeutics sits at #5 (score 39.5).
Open the related Eternal Search page
Sources
Top 10 Longevity & Anti-Aging Breakthroughs of 2025 - Healthspan
Cellular senescence as the driver of muscle aging connects a commercial editorial's specific claim to both Eternal Search's glossary entry on the mechanism and to Deciduous Therapeutics in the company ratings — grounding a news angle in an explanatory resource and a funded therapeutic target, while flagging the source's commercial context and the early clinical stage of senolytics.